Page last updated: 2024-09-04

cryptotanshinone and Colorectal Neoplasms

cryptotanshinone has been researched along with Colorectal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Inoue, H; Kageyama, S; Kawauchi, A; Kim, CJ; Minami, K; Shirasawa, S; Tambe, Y; Tanaka, H; Terado, T; Tsunoda, T; Ushio, A1
Cui, S; Hu, S; Liu, W; Lu, H; Lu, L; Qin, W; Tian, Y; Wei, S; Wen, L; Yang, F; Zhang, J; Zhou, Q1
Chen, S; Guan, L; Lai, M; Li, J; Liu, Z; Wang, H; Yu, W1
Bittner, M; Datta, A; Hua, J; Lopes, R; Sima, C; Vundavilli, H1
Colburn, NH; Hua, B; Li, W; Saud, SM; Young, MR1

Other Studies

5 other study(ies) available for cryptotanshinone and Colorectal Neoplasms

ArticleYear
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells.
    International journal of oncology, 2022, Volume: 61, Issue:3

    Topics: Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Glutamine; Humans; Lipids; Lipogenesis; Pancreatic Neoplasms; Phenanthrenes; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species; Signal Transduction

2022
The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer.
    Scientific reports, 2019, 09-10, Volume: 9, Issue:1

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phenanthrenes; Phosphorylation; Prognosis; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; STAT3 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019
LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis.
    Pharmacological research, 2020, Volume: 153

    Topics: Animals; Apoptosis; Caco-2 Cells; Cell Cycle; Cell Movement; Cell Proliferation; Colorectal Neoplasms; HCT116 Cells; Humans; Mice, Inbred ICR; Mice, Inbred NOD; Mice, SCID; Molecular Docking Simulation; Neoplasm Invasiveness; Neoplasm Metastasis; Phenanthrenes; Protein Binding; STAT3 Transcription Factor; Toxicity Tests, Acute; Xenograft Model Antitumor Assays

2020
Targeting oncogenic mutations in colorectal cancer using cryptotanshinone.
    PloS one, 2021, Volume: 16, Issue:2

    Topics: Cell Death; Cell Proliferation; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Mutation; Phenanthrenes; Signal Transduction

2021
Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro.
    Molecular and cellular biochemistry, 2015, Volume: 406, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Inhibitor of Apoptosis Proteins; Phenanthrenes; STAT3 Transcription Factor; Survivin

2015